CVS HEALTH Corp Quarterly Debt-to-equity in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CVS HEALTH Corp quarterly Debt-to-equity history and growth rate from Q3 2018 to Q3 2024.
  • CVS HEALTH Corp Debt-to-equity for the quarter ending September 30, 2024 was 234 %, a 0.14% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 234 +0.32 +0.14% Sep 30, 2024
Q2 2024 235 +3.43 +1.48% Jun 30, 2024
Q1 2024 236 +14.8 +6.66% Mar 31, 2024
Q4 2023 236 +19.1 +8.83% Dec 31, 2023
Q3 2023 234 +19.1 +8.91% Sep 30, 2023
Q2 2023 231 +18.9 +8.91% Jun 30, 2023
Q1 2023 221 +6.88 +3.21% Mar 31, 2023
Q4 2022 216 -0.16 -0.07% Dec 31, 2022
Q3 2022 215 -6.69 -3.02% Sep 30, 2022
Q2 2022 212 -14.8 -6.54% Jun 30, 2022
Q1 2022 215 -20.2 -8.61% Mar 31, 2022
Q4 2021 217 -25.6 -10.6% Dec 31, 2021
Q3 2021 221 -24.7 -10% Sep 30, 2021
Q2 2021 227 -22.5 -9.01% Jun 30, 2021
Q1 2021 235 -17.5 -6.94% Mar 31, 2021
Q4 2020 242 -13.5 -5.27% Dec 31, 2020
Q3 2020 246 -7 -2.77% Sep 30, 2020
Q2 2020 249 -5.3 -2.08% Jun 30, 2020
Q1 2020 252 -5.59 -2.17% Mar 31, 2020
Q4 2019 256 +3.18 +1.26% Dec 31, 2019
Q3 2019 253 +20 +8.57% Sep 30, 2019
Q2 2019 255 Jun 30, 2019
Q1 2019 258 Mar 31, 2019
Q4 2018 252 Dec 31, 2018
Q3 2018 233 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.